Matching-Adjusted Indirect Treatment Comparison of Ozanimod Versus Teriflunomide for Relapsing Multiple Sclerosis
Publication date: Available online 25 April 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Stanley Cohan, Tom Tencer, Stella Arndorfer, Xuelian Zhu, Marko Zivkovic, Jinender Kumar
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
More News: Multiple Sclerosis | Neurology